eLife · 2020 · 21 citations · 57 references
Life SciencesBiologyMolecular BiologyHost-pathogen InteractionsMolecular VirologyVirologyAntiviral ImmunityHost-virus InteractionsViral EntryViral PathogenesisVirus EntryVirus-host InteractionsCofactor RecruitmentConformational Changes In Capsid ProteinsNuclear Import PathwaysNuclear Protein ImportProtein Nuclear ImportSensitivityViral Dna ReplicationViral Nuclear Entry
The type one interferon induced restriction factor Myxovirus resistance B (MxB) restricts HIV-1 nuclear entry evidenced by inhibition of 2-LTR but not linear forms of viral DNA. The HIV-1 capsid is the key determinant of MxB sensitivity and cofactor binding defective HIV-1 capsid mutants P90A (defective for cyclophilin A and Nup358 recruitment) and N74D (defective for CPSF6 recruitment) have reduced dependency on nuclear transport associated cofactors, altered integration targeting preferences and are not restricted by MxB expression. This has suggested that nuclear import mechanism may determine MxB sensitivity. Here we have use genetics to separate HIV-1 nuclear import cofactor dependence from MxB sensitivity. We provide evidence that MxB sensitivity depends on HIV-1 capsid conformation, rather than cofactor recruitment. We show that depleting CPSF6 to change nuclear import pathway does not impact MxB sensitivity, but mutants that recapitulate the effect of Cyclophilin A binding on capsid conformation and dynamics strongly impact MxB sensitivity. We demonstrate that HIV-1 primary isolates have different MxB sensitivities due to cytotoxic T lymphocyte (CTL) selected differences in Gag sequence but similar cofactor dependencies. Overall our work demonstrates a complex relationship between cyclophilin dependence and MxB sensitivity likely driven by CTL escape. We propose that cyclophilin binding provides conformational flexibility to HIV-1 capsid facilitating simultaneous evasion of capsid-targeting restriction factors including TRIM5 as well as MxB.
57
HIV evolution: CTL escape mutation and reversion after transmission
Alasdair Leslie, Katja Pfafferott, Polan Chetty et al. · Nature Medicine · 2004 · 853 citations
Jesus F. Salazar-Gonzalez, Maria G. Salazar, Brandon F. Keele et al. · The Journal of Experimental Medicine · 2009 · 787 citations · Full text
Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection
Caroline Goujon, Olivier Moncorgé, Hélène Bauby et al. · Nature · 2013 · 570 citations
MX2 is an interferon-induced inhibitor of HIV-1 infection
Melissa Kane, Shalini S. Yadav, Julia Bitzegeio et al. · Nature · 2013 · 502 citations · Full text